Intuitive Surgical
Intuitive Surgical, Inc. (Nasdaq: ISRG) develops and sells robotic-assisted systems and related products and services for minimally invasive surgery and diagnostic procedures. Its da Vinci platforms support procedures across general, urologic, gynecologic, cardiothoracic, and head and neck surgery, while its Ion… From the company’s description.
In fiscal 2025, Intuitive Surgical reported revenue of $10.06B, up 20.5% from fiscal 2024, and net income of $2.88B. Its operating margin was 29.3%, and operations generated $3.03B in cash. Over the twelve months to Sep 30, 2026, revenue was $11.58B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Intuitive Surgical does
In the company’s own words
Intuitive Surgical, Inc. (Nasdaq: ISRG) develops and sells robotic-assisted systems and related products and services for minimally invasive surgery and diagnostic procedures. Its da Vinci platforms support procedures across general, urologic, gynecologic, cardiothoracic, and head and neck surgery, while its Ion endoluminal system helps physicians perform minimally invasive lung biopsies. The company also sells reusable and single-use instruments, staplers, energy products, and accessories, and provides customer training, system installation and maintenance, operational support, and digital tools for learning, procedure insights, and program analytics. Its customers include hospitals, healthcare systems, surgeons, physicians, and operating-room care teams. Major product brands include da Vinci, Ion, SureForm, Firefly, SimNow, and My Intuitive. Intuitive launched its first da Vinci system in 1999 and received FDA clearance for general laparoscopic surgery in 2000; Ion received FDA clearance in 2019. The company’s 2025 fiscal-year revenue was not available in the supplied information. Its website is www.intuitive.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- SUNNYVALE, CA
- Fiscal year end
- December
- CIK
- 1035267
- SIC
- 3842
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Intuitive Surgical — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Intuitive Surgical · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Intuitive Surgical’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Intuitive Surgical and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Intuitive Surgical's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Intuitive Surgical's last four quarterly filings that the numbers alone won't show?”